Acetaminophen and codeine phosphate and Humira drug interactions - from FDA reports


Drug interactions are reported among people who take Acetaminophen and codeine phosphate and Humira together. This study is created by eHealthMe based on reports of 204 people who take Acetaminophen and codeine phosphate and Humira from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Dec, 06, 2018

204 people who take Acetaminophen and codeine phosphate, Humira are studied.


Number of reports submitted per year:

Acetaminophen and codeine phosphate and Humira drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Headache (pain in head)
  2. Nausea (feeling of having an urge to vomit)
  3. Agitation (state of anxiety or nervous excitement)
  4. Anger
  5. Mood swings (an extreme or rapid change in mood)
1 - 6 months:
  1. Dyspnoea (difficult or laboured respiration)
  2. Alveolitis (inflammation in the socket of a tooth)
  3. Oedema peripheral (superficial swelling)
  4. Arthralgia (joint pain)
  5. Dizziness
1 - 2 years:
  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Drug hypersensitivity
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  4. Impaired healing
  5. Localised infection (infection at the single location)
2 - 5 years:
  1. Chills (felling of cold)
  2. Pyrexia (fever)
  3. Urinary tract infection
  4. Aspergillosis (an infection caused by a fungus called aspergillus)
  5. Cardiac arrest
5 - 10 years:
  1. Large granular lymphocytosis (increased number of large granular white blood cells)
  2. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Marrow hyperplasia (increased bone marrow)
  5. Pyrexia (fever)
10+ years:

n/a

not specified:
  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Pneumonia
  3. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  4. Arthralgia (joint pain)
  5. Oedema peripheral (superficial swelling)

Click here to view more results or personalize the results to your gender and age

Most common drug interactions by gender *:

female:
  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  3. Dizziness
  4. Interstitial lung disease
  5. Scab (a hard coating on the skin formed during the wound healing)
male:
  1. Large granular lymphocytosis (increased number of large granular white blood cells)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Pyrexia (fever)
  4. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  5. Splenomegaly (enlargement of spleen)

Click here to view more results or personalize the results to your gender and age

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:
  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Drug hypersensitivity
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  4. Impaired healing
  5. Localised infection (infection at the single location)
30-39:
  1. Alopecia (absence of hair from areas of the body)
  2. Osteonecrosis (death of bone)
  3. Impaired work ability
  4. Nephrolithiasis (calculi in the kidneys)
  5. Neuropathy peripheral (surface nerve damage)
40-49:
  1. Infection
  2. Psoriasis (immune-mediated disease that affects the skin)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Coagulopathy (blood's ability to clot is impaired)
  5. Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful)
50-59:
  1. Pneumonia
  2. Agitation (state of anxiety or nervous excitement)
  3. Anaemia (lack of blood)
  4. Anger
  5. Arthralgia (joint pain)
60+:
  1. Weight decreased
  2. Dizziness
  3. Splenomegaly (enlargement of spleen)
  4. Pyrexia (fever)
  5. Erythema (redness of the skin)

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you take Acetaminophen and codeine phosphate and Humira?


You are not alone:




Related studies

Acetaminophen and codeine phosphate

Acetaminophen and codeine phosphate has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. (latest outcomes from Acetaminophen and codeine phosphate 3,208 users)

Humira

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. (latest outcomes from Humira 443,044 users)


Interactions between Acetaminophen and codeine phosphate and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Humira and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Acetaminophen and codeine phosphate and Humira
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Acetaminophen and codeine phosphate and Humira (67,880 reports studied)

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!